Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PRADAXA DIN 02312441

Status: Marketed
Holder: BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Molecule: DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE)
Available to quote

Health Canada record

Active ingredient(s)DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCB01AE07 DABIGATRAN ETEXILATE
Original market date03-Jul-2008
Current status date03-Jul-2008
SourceHealth Canada DPD

Establishment licence of the holder

Boehringer Ingelheim (Canada) Ltd Ltee — licence 100187, currently licensed, last inspection rating C (2025-03-03).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE)

DINProductCompanyFormStrengthStatus
02468905APO-DABIGATRANAPOTEX INCCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MGMarketed
02468913APO-DABIGATRANAPOTEX INCCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MGMarketed
02468891APO-DABIGATRANAPOTEX INCCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MGMarketed
02358808PRADAXABOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MGMarketed
02312433PRADAXABOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MGCancelled Post Market
02463466TEVA-DABIGATRANTEVA CANADA LIMITEDCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MGCancelled Pre Market
02463458TEVA-DABIGATRANTEVA CANADA LIMITEDCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
136422012-09-07Supplement to a New Drug Submission (SNDS)Product name change
96042008-06-10New Drug Submission (NDS)
Request a quote for PRADAXA

How to read a Canadian DIN record